Mithu Maheswaranathan, MD

I think this one looks clearer… the text is darker on this one!

CC for interest
@kristenyoung.bsky.social
@rheumcat.bsky.social
@lupusdnadoc.bsky.social
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusresearch.bsky.social

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋

Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance
🔸Management of Comorbidities

➠ Read the Full Guideline here: acr.tw/47mkegj

#RheumSky #SLE #Rheumatology

That’s a wrap on #ACR25. Great to connect with the #rheumsky #meded community IRL! @davidleverenz.bsky.social @mithurheum.bsky.social @pedsrheum2connect.bsky.social @washumedrheum.bsky.social

🆕 Clinical Year in Review at #ACR25
By Dr. Bryant England @unmc.bsky.social

🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?

#RheumSky #MedSky #YearInReview

🆕 Secrets & Pearls of #Rheumatology at #ACR25 | Part 1 by Dr. Janet Pope

🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE 
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease

#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens

@rheumcat.bsky.social
@kristenyoung.bsky.social
@lupuschat.bsky.social
@lupusdnadoc.bsky.social
@lupusencyclopedia.bsky.social
@lupusresearch.bsky.social

🆕 ACR 2025 Guidelines for Treatment of Systemic Lupus Erythematosus 🦋

#ACR25 #Lupus #RheumSky

🏷️ for Interest
@rheumnow.bsky.social
@jeffsparks.bsky.social
@pulmpeeps.bsky.social
@icuonepager.bsky.social
@drpujamehta1.bsky.social
@pulmtoilet.bsky.social
@pulmcrit.bsky.social
@thanhneville.medsky.social
@critconcepts.bsky.social
@gretchemaben.bsky.social
@laxswamy.bsky.social

🆕 Collaboration with RheumNow 🔵
*3-Part Series on Interstitial Lung Disease*

Part 3️⃣: Treatment of #ILD
💊 Medication Options for Rx of ILD
🫁 How to Treat Different ILD Subtypes
🚶🏻‍♀️Holistic Approach to Management ❌🚬

#RheumSky #PulmSky #IPF #Rheum #InterstitialLungDisease

Thank you! 😊

🏷️ for Interest
@jeffsparks.bsky.social
@pulmpeeps.bsky.social
@icuonepager.bsky.social
@nickmark.bsky.social
@drpujamehta1.bsky.social
@rheumcat.bsky.social
@didemsayginmd.bsky.social
@kristenyoung.bsky.social
@pulmtoilet.bsky.social
@pulmcrit.bsky.social

🆕 Collaboration with RheumNow 🔵
3-Part Series on Interstitial Lung Disease

Part 2: Diagnosis & Subtypes of #ILD
👩🏻‍⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging

#RheumSky #PulmSky #MedSky #InterstitialLungDisease

Infographic showing different organ systems affected by Behcets: oral/genital ulcers, skin, vascular, GI, neurologic, ocular and more.

🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫

👄 Oral and Genital Ulcers
🩸 DVT, Arterial Aneurysm
👁️ Uveitis
🧠 Neurologic Involvement
🖐️ Cutaneous Disease / Pathergy

#RheumSky #Behcets #Rheumatology

So often for FUO consults with ID and Heme/Onc 😂

🆕 2024 ACR Guidelines for Screening, Treatment and Management of Lupus Nephritis 🫘
• Just Released: May 7, 2025 🔥

🔸 New Recommendations for Triple Therapy for Class III/IV + V Lupus Nephritis 🦋
🔸 Reduced ⇣ Dose of PO Steroids after IV Pulse! 💊

#LupusNephritis #RheumSky #NephSky #Lupus

Oh sounds interesting! Look forward to reading that.

🆕 PJP Prophylaxis in #Rheumatology 🫁

🔹Discuss risk factors for PJP infection
🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk
🔹Review Treatment options and when to stop PPx?

#MedSky #RheumSky #PulmSky #PJP

💫 Check out the new Rheum Madness x Rheum One Pagers bracket infographic! 🎉🏀📟

📖 Read most pivotal, innovative studies in #rheum in past 2 yrs
🎙️ Listen to the Rheum Madness podcasts
🏀 Submit Brackets before April 1

@rheummadness.bsky.social
@davidleverenz.bsky.social
@larneson.bsky.social

@lupuschat.bsky.social @lupusdnadoc.bsky.social @ashira-md.bsky.social @alhkim.bsky.social @rheumcat.bsky.social @kristenyoung.bsky.social @creakyjoints.bsky.social @lupusresearch.bsky.social

🆕 #Obinutuzumab (Obi) in Lupus Nephritis: the REGENCY Trial

Phase 3 RCT: Obi vs PBO
🫘 Pts w/ SLE nephritis Class III/IV ± 5
🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids)
📊 Obi: ⇡rate of renal response and improved renal outcomes

#LupusNephritis #RheumSky #NephSky #MedSky #Lupus

Yes good Q whether earlier targeting in the B-cell pathway with inebilizumab will make a significant difference with broader B cell depletion!

Wonder if anyone else on #RheumSky has thoughts!

🆕 Visual Abstract with Healio Rheumatology 🟢

🔥 New Therapy for IgG4-Related Disease: INEBILIZUMAB

💉 RCT of inebilizumab (anti-CD19) vs placebo
👥 Adult pts with IgG4-RD involving ≥ 2 organs
📊 Results:⇣flare rate,⇡remission

#IgG4RD #RareDiseases #Rheumatology #Inebilizumab

Love this #HealthLiteracy 🙌🏽

Happy holidays from the Duke Rheum crew ❄️ ⛄️ 🎄 @mithurheum.bsky.social

Had so much fun! Thanks for hosting us #DukeRheum #Rheumatology ❄️🎄🎁

Without action, the ongoing #rheumatology physician shortage will only get worse…

@thedaoindex.bsky.social @rheumcat.bsky.social @kristenyoung.bsky.social @vksandhumd.bsky.social

Excited to have the opportunity to present on Physician #Burnout in Rheumatology at our division Grand Rounds today.

Thankful many advocates have been voices on this important topic in our current healthcare climate & trend of physicians exiting clinical medicine!

That’s wild! The journal should help the authors make one if desired

🆕 #ACR24 | Updated Guidelines for Lupus Nephritis Treatment & Management 🫘

Highlights 🔶
• Critical role of renal biopsy
• Differences for treatment by LN Class
• Adjunctive Rx w/ HCQ & RAASi
• GC pulse ⇢ *moderate/low* dose PDN

#Lupus #NephSky #RheumSky #Rheumatology #MedSky